PATENT CLAIM ANALYSIS

Application Number: 15759723
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-09
Patent Classification: ["424", "085200"]

Abstract:
This disclosure describes an adaptive NK cell, an isolated population of adaptive Natural Killer (NK) cells, a composition including an adaptive NK cell, and methods for producing, preparing, and using an adaptive NK cell or an isolated population or composition including an adaptive NK cell. The adaptive NK cells may be used to treat a viral infection or a tumor.

Claim (Index 55):
The composition of  claim 54 , wherein\n (i) the inhibitor of the production of ROS comprises a catalase; or (ii) the ROS production inhibitor or the CD155 inhibitor is present in an amount sufficient to reduce the expression of CD155 on a myeloid-derived suppressor cell (MDSC).

Metadata:
- Claim Count in Document: 5.0
- Percentile: 90.0
- Lexical Diversity: 1.91667
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['12855203', '13865762', '13946266', '14547084', '15167166']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6990760679422022
- 35 USC 102 Novelty (BERT): 0.5371589924170411
- Combined Prediction Score: 0.6828843603896861
- Mean Citation Score: 332.60156
- Max Citation Score: 374.96857
- Similarity Product: 243.51947279693485

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test